Originally designed for Ebola patients, the European Air Ambulance's Infectious Disease Unit now also serves Covid-19 patients. Developed in collaboration with air ambulance tech specialist AAT and decontamination equipment manufacturer VersarPPS, this unit aligns with European Air Ambulance protocols and is swiftly installable in Learjet 45XR air ambulances.
The unit features a lightweight, ergonomic modular tent system with EASA certification. Its flame-resistant PVC interior is tear-resistant and impermeable to biofluids. The tent, designed for single-patient transport, has a negative pressure enclosure ensuring no direct contact between the patient and the aircraft. Patients enter through a foldable airlock, ensuring safety and isolation.
Inside, patients can move freely with essential medical equipment, food, and drink at their disposal. Post-mission, all used equipment and waste are thoroughly disinfected and incinerated. The aircraft boasts an FFP3 filtration unit, adhering to CDC recommendations, and allows medical crew access via PVC sleeves, ensuring patient monitoring and care.
Dedicated crew members, trained for these missions, ensure readiness between 4 to 12 hours post-activation. The unit's efficacy was proven in March 2015 during a mission transporting a British national from Sierra Leone to the UK. This state-of-the-art Infectious Disease Unit underscores EAA's commitment to delivering top-tier aeromedical solutions globally.